URA vs. TRVI
URA (Global X Uranium ETF) is Commodity Producers Equities fund tracking the Solactive Global Uranium & Nuclear Components Total Return Index, while TRVI (Trevi Therapeutics, Inc.) is a stock. Over the past 5 years, URA returned 18.77%/yr vs 44.83%/yr for TRVI. At a 0.17 correlation, their price movements are largely independent.
Performance
URA vs. TRVI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, URA achieves a 6.53% return, which is significantly lower than TRVI's 13.50% return.
URA
- 1D
- 1.54%
- 1M
- -14.61%
- YTD
- 6.53%
- 6M
- 3.57%
- 1Y
- 32.44%
- 3Y*
- 32.17%
- 5Y*
- 18.77%
- 10Y*
- 15.90%
TRVI
- 1D
- 5.57%
- 1M
- -6.94%
- YTD
- 13.50%
- 6M
- 11.28%
- 1Y
- 130.31%
- 3Y*
- 75.70%
- 5Y*
- 44.83%
- 10Y*
- —
URA vs. TRVI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
URA Global X Uranium ETF | 6.53% | 67.18% | -0.58% | 46.25% | -11.32% | 57.57% | 41.33% | -5.64% |
TRVI Trevi Therapeutics, Inc. | 13.50% | 203.88% | 207.46% | -30.57% | 146.74% | -67.68% | -35.47% | -60.53% |
Correlation
The correlation between URA and TRVI is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since May 7, 2019 | 0.17 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
URA vs. TRVI — Risk / Return Rank
URA
TRVI
URA vs. TRVI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Uranium ETF (URA) and Trevi Therapeutics, Inc. (TRVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| URA | TRVI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.54 | ||
| Sortino ratioReturn per unit of downside risk | -1.52 | ||
| Omega ratioGain probability vs. loss probability | 1.14 | 1.35 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | 1.04 | 4.44 | -3.41 |
| Martin ratioReturn relative to average drawdown | 2.30 | 10.40 | -8.09 |
Loading charts...
Drawdowns
URA vs. TRVI - Drawdown Comparison
The maximum URA drawdown since its inception was -93.54%, roughly equal to the maximum TRVI drawdown of -95.45%. Use the drawdown chart below to compare losses from any high point for URA and TRVI.
Loading charts...
Drawdown Indicators
| URA | TRVI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.54% | -95.45% | +1.91% |
Max Drawdown (1Y)Largest decline over 1 year | -31.48% | -29.50% | -1.98% |
Max Drawdown (3Y)Largest decline over 3 years | -37.81% | -61.96% | +24.15% |
Max Drawdown (5Y)Largest decline over 5 years | -37.90% | -80.26% | +42.36% |
Max Drawdown (10Y)Largest decline over 10 years | -61.45% | — | — |
Current DrawdownCurrent decline from peak | -48.34% | -7.73% | -40.61% |
Average DrawdownAverage peak-to-trough decline | -74.94% | -61.49% | -13.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.12% | 12.58% | +1.54% |
Volatility
URA vs. TRVI - Volatility Comparison
Global X Uranium ETF (URA) has a higher volatility of 17.69% compared to Trevi Therapeutics, Inc. (TRVI) at 13.78%. This indicates that URA's price experiences larger fluctuations and is considered to be riskier than TRVI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| URA | TRVI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.69% | 13.78% | +3.91% |
Volatility (6M)Calculated over the trailing 6-month period | 39.95% | 39.38% | +0.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.24% | 60.39% | -9.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.96% | 88.26% | -44.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.91% | 99.35% | -61.44% |
Dividends
URA vs. TRVI - Dividend Comparison
URA's dividend yield for the trailing twelve months is around 4.58%, while TRVI has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TRVI Trevi Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
URA Global X Uranium ETF | 4.58% | 4.88% | 2.86% | 6.07% | 0.76% | 5.84% | 1.69% | 1.66% | 0.44% | 2.03% | 7.28% | 1.96% |
Frequently Asked Questions
URA and TRVI have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
URA has higher volatility (17.69%) compared to TRVI (13.78%). In terms of maximum drawdown, URA dropped -93.54% vs TRVI's -95.45%.
TRVI currently has the higher Sharpe Ratio (2.17 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for URA and TRVI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer